M&A Deal Summary

Cordlife Group Acquires HealthBaby Biotech

On January 3, 2018, Cordlife Group acquired healthcare services company HealthBaby Biotech for 7M USD

Acquisition Highlights
  • This is Cordlife Group’s 1st transaction in the Healthcare Services sector.
  • This is Cordlife Group’s largest (disclosed) transaction.
  • This is Cordlife Group’s 1st transaction in China.

M&A Deal Summary
Date 2018-01-03
Target HealthBaby Biotech
Sector Healthcare Services
Buyer(s) Cordlife Group
Deal Type Add-on Acquisition
Deal Value 7M USD

Target

HealthBaby Biotech

Hong Kong, China
HealthBaby Biotech (Hong Kong) Co., Ltd. is a cord blood laboratory that engages in the collection, storage and processing of umbilical cord tissues. HealthBaby Biotech (Hong Kong) Co., Ltd. was established in 2001 and is based in Hong Kong.

Search 200,500 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Cordlife Group

Singapore, Singapore
Category Company
Founded 2001
Sector Healthcare Services
Revenue 60M SGD (2017)
DESCRIPTION

Cordlife Group Ltd. is a healthcare company that provides cord blood and cord lining banking services. Cordlife Group Ltd. was founded in 2001 and is headquartered in Singapore.

DEAL STATS #
Overall 1 of 1
Sector (Healthcare Services) 1 of 1
Type (Add-on Acquisition) 1 of 1
Country (China) 1 of 1
Year (2018) 1 of 1
Size (of disclosed) 1 of 1
Mergr

Product

Company

Legal